InsidersTradesSigma
한미사이언스 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 한미사이언스 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 한미사이언스 has published 202 reports. Market capitalisation: €2,119.4bn. The latest transaction was reported on 7 July 2026 (Other). Among the most active insiders: 임종훈. Every trade is accessible without an account.
202
Insider Decl.
0
Thresholds
·
24 ops.
Buy Volume
€281m
17 ops.
Sell Volume
33Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 12,441 of 25,898 companies
53.1
score / 100
Value48
Quality59
FCF yld1.2%
Earn yld5.1%
EV/EBITDA16.4x
ROE15%
Gross mgn23%
Net mgn8.7%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 7 July 2026
Declarations202 total
25 of 202 declarations
About 한미사이언스
Hanmi Science is a South Korean company focused on the health and pharmaceutical sector. It is listed on the XKRX market.